Reach Us +44 20 3936 9064


Cryptococcosis: An Emerging Airborne Mycosis of Global Concern | OMICS International | Abstract
ISSN: 2167-7719

Air & Water Borne Diseases
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Cryptococcosis: An Emerging Airborne Mycosis of Global Concern

Mahendra Pal1* and Pratibha Dave22

1Veterinary Public Health (UNDP), Addis Ababa University, Ethiopia.

2Welfare Hospital and Research Centre, Bharauch-392001, Gujarat, India.

*Corresponding Author:
Mahendra Pal
Ex-Professor of Veterinary Public Health (UNDP)
Addis Ababa University, Ethiopia
Tel: +251 114 338 450
E-mail: [email protected]

Received Date: May 05, 2016; Accepted Date: June 16, 2016; Published Date: June 25, 2016

Citation: Pal M, Dave P (2016) Cryptococcosis: An Emerging Airborne Mycosis of Global Concern. Air Water Borne Diseases 5:127. doi:10.4172/2167- 7719.1000127

Copyright: © 2016 Pal M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Cryptococcosis, an emerging highly infectious respiratory mycosis, is mainly caused by Cryptococcus neoformans and Cryptococcus gattii, which exist as saprobe in the environment. Currently, nine molecular types, five in C.neoformans and four in C. gattii are identified. The disease occurs in sporadic and epidemic form resulting into significant morbidity and mortality, especially in immunocompromised patients. Globally, cryptococcosis causes about 625,000 deaths annually. The clinical manifestation of pulmonary cryptococcosis includes cough, weight loss, sputum, chest pain, dysponea, fever, headache, and hemoptysis. The demonstration of pathogen both by direct microscopy in India ink and its isolation on Pal sunflower seed medium is still considered as gold standard to confirm an unequivocal diagnosis of cryptococcosis. The morphology of isolates can be easily studied in “Narayan” stain. The fluconazole, being a less toxic drug, is recommended for the management of pulmonary cryptococcosis. It is emphasized to undertake molecular characterization of Cryptococcus isolates to know the genotypes prevalent in different regions of the world. Since many laboratory in poor resource countries do not have facilities to undertake biochemical test, it is therefore, advised to use easily available, very sensitive, highly specific and low cost “Pal sunflower seed medium” to make an early diagnosis to save the life of patients from this enigmatic mycosis. Further research work on pathogenesis, epidemiology, and chemotherapy may be rewarding.